Found: 20
Select item for more details and to access through your institution.
A Real World Perspective of PARP Inhibitor Use in Gynecological Cancer Patients.
- Published in:
- Journal of Pharmacy Practice, 2023, v. 36, n. 5, p. 1134, doi. 10.1177/08971900221088793
- By:
- Publication type:
- Article
Impact of Tyrosine Kinase Inhibitor Starting Dose on Outcomes in Patients With Non-Small Cell Lung Cancer.
- Published in:
- Journal of Pharmacy Practice, 2021, v. 34, n. 1, p. 11, doi. 10.1177/0897190019840596
- By:
- Publication type:
- Article
Inpatient utilization of immune checkpoint inhibitors and clinical outcomes.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1392, doi. 10.1177/10781552221123967
- By:
- Publication type:
- Article
Alectinib-induced hemolytic anemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1251, doi. 10.1177/10781552221147840
- By:
- Publication type:
- Article
A deep dive into CDK4/6 inhibitors: Evaluating real world toxicities and treatment paradigms in the elderly population.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 14, doi. 10.1177/10781552211050106
- By:
- Publication type:
- Article
A real world analysis of first line treatment of advanced EGFR mutated non-small cell lung cancer: A multi-center, retrospective study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1140, doi. 10.1177/10781552211020798
- By:
- Publication type:
- Article
A contemporary review of rearranged during transfection-selective inhibitors.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 1, p. 175, doi. 10.1177/10781552211040542
- By:
- Publication type:
- Article
Lorlatinib induced proteinuria: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 1037, doi. 10.1177/1078155220961549
- By:
- Publication type:
- Article
Bevacizumab-induced dysphonia: A case report with brief review of literature.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 1032, doi. 10.1177/1078155219889388
- By:
- Publication type:
- Article
A retrospective analysis of tumor lysis syndrome management in a quaternary care hospital.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 2, p. 338, doi. 10.1177/1078155219846949
- By:
- Publication type:
- Article
Pemetrexed-induced severe rhabdomyolysis in lung cancer: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 2007, doi. 10.1177/1078155218816767
- By:
- Publication type:
- Article
Penetrating the evidence of EGFR and ALK tyrosine kinase inhibitors for non-small cell lung cancer brain metastases.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 623, doi. 10.1177/1078155218796695
- By:
- Publication type:
- Article
A review of a novel, Bruton’s tyrosine kinase inhibitor, ibrutinib.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 1, p. 92, doi. 10.1177/1078155214561281
- By:
- Publication type:
- Article
A Comprehensive Review of Contemporary Literature for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer and Their Toxicity.
- Published in:
- Lung Cancer: Targets & Therapy, 2020, v. 11, p. 73, doi. 10.2147/LCTT.S258444
- By:
- Publication type:
- Article
Epidemiology and clinicopathological features of lung cancer in patients with prior history of breast cancer.
- Published in:
- SAGE Open Medicine, 2021, v. 9, p. 1, doi. 10.1177/20503121211017757
- By:
- Publication type:
- Article
Epidemiology and clinicopathological features of lung cancer in patients with prior history of breast cancer.
- Published in:
- SAGE Open Medicine, 2021, v. 9, p. 1, doi. 10.1177/20503121211017757
- By:
- Publication type:
- Article
An Overview of the Changing Landscape of Treatment for Advanced Melanoma.
- Published in:
- Pharmacotherapy, 2017, v. 37, n. 3, p. 319, doi. 10.1002/phar.1895
- By:
- Publication type:
- Article
Profile of Capmatinib for the Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC): Patient Selection and Perspectives.
- Published in:
- Cancer Management & Research, 2023, v. 15, p. 1233, doi. 10.2147/CMAR.S386799
- By:
- Publication type:
- Article
A Retrospective Study of the Effect of Metformin on Patients with Metastatic Prostate Cancer.
- Published in:
- Clinical Medicine Insights: Oncology, 2023, p. 1, doi. 10.1177/11795549231152073
- By:
- Publication type:
- Article
Osimertinib in EGFR-Mutated Lung Cancer: A Review of the Existing and Emerging Clinical Data.
- Published in:
- OncoTargets & Therapy, 2021, v. 14, p. 4579, doi. 10.2147/OTT.S227032
- By:
- Publication type:
- Article